The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis
Open accessAbstract
BACKGROUND: Neurocysticercosis is the main cause of adult-onset seizures in the developing world. Whether therapy with antiparasitic agents results in improved seizure control has been questioned because of the lack of adequate, controlled studies. METHODS: We conducted a double-blind, placebo-controlled trial in which 120 patients who had living cysticerci in the brain and seizures treated with antiepileptic drugs were randomly assigned to receive either 800 mg of albendazole per day and 6 mg of dexamethasone per day for 10 days (60 patients) or two placebos (60 patients). The patients were followed for 30 months or until they had been seizure-free for 6 months after the doses of the antiepileptic drugs had been tapered. The efficacy of treatment was measured as the decrease in the number of seizures after treatment. RESULTS: In the albendazole group, there was a 46 percent reduction in the number of seizures (95 percent confidence interval, -74 to 83 percent) during months 2 to 30 after treatment. This reduction, which was not statistically significant, was composed of a nonsignificant reduction of 41 percent in the number of partial seizures (95 percent confidence interval, -124 to 84 percent) and a significant 67 percent reduction in the number of seizures with generalization (95 percent confidence interval, 20 to 86 percent). Most of the difference in the number of partial seizures was attributable to a few patients who had many seizures during follow-up. The proportions of patients who had partial seizures during follow-up were similar in the two groups (19 of 57 in the albendazole group and 16 of 59 in the placebo group), but the patients in the placebo group had a greater tendency to have seizures with generalization (22 of 59, vs. 13 of 57 in the albendazole group; risk ratio, 1.63; 95 percent confidence interval, 0.91 to 2.92). More of the intracranial cystic lesions resolved in the albendazole group than in the placebo group. With the sole exception of abdominal pain, side effects did not differ significantly between the two groups. CONCLUSIONS: In patients with seizures due to viable parenchymal cysts, antiparasitic therapy decreases the burden of parasites and is safe and effective, at least in reducing the number of seizures with generalization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tsang, V. C. W., Brand, J. A., & Boyer, A. E. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.1.50 · Cited by 836
García, H. H., Gonzalez, A. E., Evans, C. A., & Gilman, R. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14117-7 · Cited by 835
Self-citationThe Treatment of Epilepsy : Principles and Practice
Wyllie, E. (1997) · Cited by 706
Current Consensus Guidelines for Treatment of Neurocysticercosis
García, H. H., Evans, C. A. W., Nash, T. E., Takayanagui, O. M., White, A. C., Botero, D., Rajshekhar, V., Tsang, V. C. W., Schantz, P. M., Allan, J. C., et al. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.747-756.2002 · Cited by 508
Self-citationDel Brutto, O. H., & Sotelo, J. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.6.1075 · Cited by 334
Self-citationCarpio, A. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00454-1 · Cited by 321
Garcia, H. H., & Del Brutto, O. H. (2000) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70220-8 · Cited by 259
Self-citationCysticercosis: an analysis and follow-up of 450 cases.
Dixon, H. B. F., & Lipscomb, F. M. (1961) · Biblioteca Digital (Real Academia Nacional de Medicina) · Cited by 249
Magnitude of the Disease Burden from Neurocysticercosis in a Developing Country
Bern, C., Garcia, H. H., Evans, C., Gonzalez, A. E., Verastegui, M., Tsang, V. C. W., & Gilman, R. H. (1999) · Clinical Infectious Diseases · doi:10.1086/313470 · Cited by 218
Self-citationComparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis
Sotelo, J., del Brutto, O. H., Penagos, P., Escobedo, F., Torres, B., Rodriguez-Carbajal, J., & Rubio-Donnadieu, F. (1990) · Journal of Neurology · doi:10.1007/bf00314663 · Cited by 214
Self-citationIs the Course of Neurocysticercosis Modified by Treatment With Antihelminthic Agents?
Carpio, A., Santillán, F., León, P., Flores, C., & Hauser, W. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430180088010 · Cited by 169
Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis
Carpio, A., & Hauser, W. A. (2002) · Neurology · doi:10.1212/01.wnl.0000036320.69823.ea · Cited by 161
Neurocysticercosis in Radiographically Imaged Seizure Patients in U.S. Emergency Departments1
Ong, S., Talan, D. A., Moran, G. J., Mower, W. R., Newdow, M., Tsang, V. C. W., Pinner, R. W., & the EMERGEncy ID NET Study Group (2002) · Emerging infectious diseases · doi:10.3201/eid0806.010377 · Cited by 149
Schantz, P. M., Wilkins, P. P., & Tsang, V. C. W. (2014) · ASM Press eBooks · doi:10.1128/9781555816957.ch12 · Cited by 145
Albendazole therapy for neurocysticercosis
Garcia, H. H., Gilman, R. H., Horton, J. D., Martinez, M., Herrera, G., Altamirano, J., Cuba, J. M., Rios-Saavedra, N., Verástegui, M., Boero, J., et al. (1997) · Neurology · doi:10.1212/wnl.48.5.1421 · Cited by 107
Self-citationMedical Treatment of Cysticercosis--Ineffective
Kramer, L. D. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540250109020 · Cited by 77
Spontaneous radiographic disappearance of cerebral cysticercosis: Three cases
Miller, B. L., Grinnell, V. S., Goldberg, M. A., & Heiner, D. C. (1983) · Neurology · doi:10.1212/wnl.33.10.1377 · Cited by 71
Classifying Seizures and Epilepsy: A Synopsis
Sirven, J. I. (2002) · Seminars in Neurology · doi:10.1055/s-2002-36644 · Cited by 37
Cited by
Clinical symptoms, diagnosis, and treatment of neurocysticercosis
Garcia, H. H., Nash, T. E., & Del Brutto, O. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70094-8 · Cited by 594
Self-citationNeurocysticercosis: updated concepts about an old disease
Garcia, H. H., & Del Brutto, O. H. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70194-0 · Cited by 554
Self-citationWhite, A. C., Coyle, C. M., Rajshekhar, V., Singh, G., Hauser, W. A., Mohanty, A., Garcia, H. H., & Nash, T. E. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1084 · Cited by 285
Self-citationArroyo, G., Bustos, J. A., Lescano, A. G., Gonzales, I., Saavedra, H., Rodriguez, S., Pretell, E. J., Bonato, P. S., Lanchote, V. L., Takayanagui, O. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz085 · Cited by 19
Self-citation
Metadata
- Authors
- Garcia, H. H., Pretell, E. J., Gilman, R. H., Martinez, S. M., Moulton, L. H., Del Brutto, O. H., Herrera, G., Evans, C. A. W., & Gonzalez, A. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-01-15
- Volume
- 350
- Issue
- 3
- Pages
- 249-258
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2125910347
- Cited by
- 418
- References
- 19
- FWCI
- 13.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.